Multi-Source Transcriptomic and Structural Prioritization of Adansonia digitata Phytochemicals in Myocardial Infarction

Background/Objectives: Myocardial infarction (MI) remains a major therapeutic challenge, and the molecular targets potentially associated with the cardiovascular activity of Adansonia digitata phytochemicals remain incompletely characterized. This study integrated phytochemical, transcriptomic, disease-gene, network, and structural evidence to prioritize candidate phytochemical–MI target associations. Methods: Ten polyphenols were selected from published LC-MS/QTOF data. Targets predicted using SwissTargetPrediction and PharmMapper were integrated with MI-associated evidence from the GSE66360 (circulating endothelial cell), GSE325257 (cardiac targeted gene-expression), and DisGeNET. An initial composite analysis generated a 19-gene discovery module for network and structural prioritization. A complementary source-resolved sensitivity analysis independently evaluated the three MI evidence sources. Selected interactions were examined by molecular docking, 200 ns molecular dynamics simulations, and MM/PBSA binding free-energy estimation. Results: Sensitivity analysis identified 189 genes supported by at least two MI evidence sources, including 21 predicted Adansonia digitata targets. Four genes (GSK3B, NOS3, SOD2, and TGFBR1) were shared between the 19-gene discovery and 21-gene sensitivity modules. Gene Ontology analysis identified 36 significantly overrepresented biological-process terms (FDR < 0.05). Docking supported the selection of chlorogenic acid and rutin for simulation with MMP2 and NOS3. MM/PBSA calculations indicated that chlorogenic acid exhibited more favorable estimated binding energies compared to rutin, especially in the case of MMP2. However, these differences were not statistically validated. Conclusions: The complementary integration strategies prioritized candidate Adansonia digitata phytochemicals and MI-associated targets and generated testable hypotheses for further investigation. These computational findings are hypothesis-generating and require experimental validation of target engagement, biological activity, pharmacokinetics, and efficacy in MI models.

Authors

Institutions

Publication Details

Journal
Pharmaceuticals
Published
2026-11-13
DOI
https://doi.org/10.3390/ph19111803
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Multi-Source Transcriptomic and Structural Prioritization of Adansonia digitata Phytochemicals in Myocardial Infarction

Ejlal Mohamed Abdullah, Mougina K. Eltahir, Mohammed M. Alshehri, Loulwah Alothman et al.
3 links
Pharmaceuticals
Computational Drug Discovery Methods
article

Multi-Source Transcriptomic and Structural Prioritization of Adansonia digitata Phytochemicals in Myocardial Infarction

Ejlal Mohamed Abdullah, Mougina K. Eltahir, Mohammed M. Alshehri, Loulwah Alothman, Alaa Alnoor Alameen, Hala Aldahshan, Marwah Mohammed Alsamhari
article en

Abstract

Background/Objectives: Myocardial infarction (MI) remains a major therapeutic challenge, and the molecular targets potentially associated with the cardiovascular activity of Adansonia digitata phytochemicals remain incompletely characterized. This study integrated phytochemical, transcriptomic, disease-gene, network, and structural evidence to prioritize candidate phytochemical–MI target associations. Methods: Ten polyphenols were selected from published LC-MS/QTOF data. Targets predicted using SwissTargetPrediction and PharmMapper were integrated with MI-associated evidence from the GSE66360 (circulating endothelial cell), GSE325257 (cardiac targeted gene-expression), and DisGeNET. An initial composite analysis generated a 19-gene discovery module for network and structural prioritization. A complementary source-resolved sensitivity analysis independently evaluated the three MI evidence sources. Selected interactions were examined by molecular docking, 200 ns molecular dynamics simulations, and MM/PBSA binding free-energy estimation. Results: Sensitivity analysis identified 189 genes supported by at least two MI evidence sources, including 21 predicted Adansonia digitata targets. Four genes (GSK3B, NOS3, SOD2, and TGFBR1) were shared between the 19-gene discovery and 21-gene sensitivity modules. Gene Ontology analysis identified 36 significantly overrepresented biological-process terms (FDR < 0.05). Docking supported the selection of chlorogenic acid and rutin for simulation with MMP2 and NOS3. MM/PBSA calculations indicated that chlorogenic acid exhibited more favorable estimated binding energies compared to rutin, especially in the case of MMP2. However, these differences were not statistically validated. Conclusions: The complementary integration strategies prioritized candidate Adansonia digitata phytochemicals and MI-associated targets and generated testable hypotheses for further investigation. These computational findings are hypothesis-generating and require experimental validation of target engagement, biological activity, pharmacokinetics, and efficacy in MI models.

PharmaceuticalsVol. 19(11)
King Saud University (SA)
Good health and well-being
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon